EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Luteolin-Loaded TGN/RAP12 Dual-Peptide Functionalized Nanoparticles: Synergistic Enhancement of BBB Penetration and Microglia Targeting in Alzheimer’s Disease

Shumeng Liu, Yue Xing, Yue Na, Hao Wu, Chi Liu, Zhigang Wang, Ning Zhang iD, Xiuhong Wu, Fang Geng

Molecules · 2026

DOI: 10.3390/molecules31040671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Shumeng Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Metabolomics Laboratory, Department of Pharmaceutical Analysis, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacoc…. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Luteolin, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The State Key Laboratory for Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lateral Project of Dong'e Ejiao Co., Ltd., Heilongjiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Luteolin (Ltn), a natural flavonoid, effectively inhibits microglial activation in Alzheimer’s disease (AD) with promising therapeutic potential, but its efficacy is severely limited by the blood–brain barrier (BBB). To overcome this obstacle, this study prepared poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs)—designated as TGN/RAP12-RBC-NPs@Ltn—which were coated with red blood cell membranes (RBCm) functionalized with two peptides, TGN (TGNYKALHPHN) and RAP12 (EAKIEKHNHYQK). The results demonstrated that TGN significantly enhanced BBB permeability, while RAP12 enabled effective targeting and delivery of TGN/RAP12-RBC-NPs@Ltn to microglial mitochondria in the brain. In addition, the presence of RBCm significantly inhibited the phagocytosis of NPs by macrophages, exerting a notable role in immune evasion. Meanwhile, the study confirmed that encapsulating Ltn within NPs significantly enhanced cognitive function in APP/PS1 mice, modulated the expression of key mitochondrial metabolic enzymes—pyruvate dehydrogenase (PDH) and its phosphorylated forms (pS232PDH, pS293PDH, pS300PDH)—in microglia, thereby ameliorating mitochondrial dysfunction and effectively regulating the neuroinflammatory environment in the mouse brain, and ultimately contributed to therapeutic efficacy. From this, it could be seen that TGN/RAP12-RBC-NPs@Ltn could significantly enhance the therapeutic effect of Ltn on AD, providing an effective treatment strategy for delaying the progression of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicrogliaLuteolinNanoparticlesBlood-Brain BarrierPeptidesAnimalsMiceMitochondriaHumansPolylactic Acid-Polyglycolic Acid CopolymerDisease Models, AnimalPhagocytosis

Stichwörter der Autor:innen

Alzheimer’s diseaseRAP12TGNluteolinnanoparticles

Substanzen

LuteolinPeptidesPolylactic Acid-Polyglycolic Acid Copolymer

Autor:innen und Institutionen

  • Metabolomics Laboratory, Department of Pharmaceutical Analysis, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, State Key Laboratory of Integration and Innovation of Classi…
  • Key Laboratory of Photochemistry Biomaterials and Energy Storage Materials of Heilongjiang Province, School of Chemistry and Chemical Engineering, Harbin Normal University, Harbin 150000, China.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi 276005, China.

ORCID-Profile: Ning Zhang

Förderung

  • The State Key Laboratory for Integration and Innovation of Classic Formula and Modern Chinese Medicine
  • Lateral Project of Dong'e Ejiao Co., Ltd.
  • Heilongjiang Province Natural Science Foundation
  • Lateral Project of Nanjing Jiumingyuan Biotechnology Co., Ltd.
  • State Key Laboratory for Integration and Innovation of Classic Formula and Modern Chinese Medicine
  • Lateral Project of Dong’e Ejiao Co., Ltd.

Zitieren

APA

Liu, S., Xing, Y., Na, Y., Wu, H., Liu, C., Wang, Z., Zhang, N., Wu, X., & Geng, F. (2026). Luteolin-Loaded TGN/RAP12 Dual-Peptide Functionalized Nanoparticles: Synergistic Enhancement of BBB Penetration and Microglia Targeting in Alzheimer’s Disease. Molecules. https://doi.org/10.3390/molecules31040671

Vancouver

Liu S, Xing Y, Na Y, Wu H, Liu C, Wang Z, et al. Luteolin-Loaded TGN/RAP12 Dual-Peptide Functionalized Nanoparticles: Synergistic Enhancement of BBB Penetration and Microglia Targeting in Alzheimer’s Disease. Molecules. 2026. doi:10.3390/molecules31040671

BibTeX
@article{Liu2026,
  author = {Liu, Shumeng and Xing, Yue and Na, Yue and Wu, Hao and Liu, Chi and Wang, Zhigang and Zhang, Ning and Wu, Xiuhong and Geng, Fang},
  title = {Luteolin-Loaded TGN/RAP12 Dual-Peptide Functionalized Nanoparticles: Synergistic Enhancement of BBB Penetration and Microglia Targeting in Alzheimer’s Disease},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31040671}
}
Kostenlos starten →